Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. NTNX
NTNX logo

NTNX Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Nutanix Inc (NTNX) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
38.240
1 Day change
-1.01%
52 Week Range
83.360
Analysis Updated At
2026/03/06
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Nutanix Inc (NTNX) is not a strong buy at the moment for a beginner investor with a long-term focus. While the company has shown strong financial growth in the latest quarter and has positive long-term growth prospects, current technical indicators, insider selling trends, and lack of immediate positive catalysts suggest holding off on purchasing the stock right now.

Technical Analysis

The MACD is positive and expanding, indicating bullish momentum. However, the RSI is neutral at 54.843, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near the pivot level of 39.342, with resistance at 41.68 and support at 37.004. This suggests limited immediate upside potential.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

The low put-call ratios indicate bullish sentiment in the options market, but the implied volatility (52.63) and IV percentile (76.89) suggest elevated risk.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
10
Buy
0

Positive Catalysts

  • Strong Q2 2026 financial performance with revenue up 10.40% YoY, net income up 82.58% YoY, and EPS up 84.21% YoY.

  • Positive long-term growth potential from partnerships with AMD, Dell, Cisco, and Red Hat.

  • Highest net-new customer additions in 8 years and mid-teens growth in TCV bookings.

Neutral/Negative Catalysts

  • Insider selling has increased significantly by 575.77% over the last month, which could indicate a lack of confidence from insiders.

  • Analysts have recently lowered price targets, reflecting concerns over supply chain issues and weaker revenue visibility.

  • No significant hedge fund activity or congress trading data to support a strong buy case.

Financial Performance

In Q2 2026, Nutanix reported revenue of $722.83M (+10.40% YoY), net income of $103.02M (+82.58% YoY), and EPS of $0.35 (+84.21% YoY). Gross margin improved slightly to 87.37%. The company demonstrated strong growth in annual recurring revenue (+16% YoY) and cRPO growth (+17% YoY), indicating solid demand.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts are mixed on NTNX. While UBS and BofA maintain Buy ratings with price targets of $60, others like Barclays, Wells Fargo, and Morgan Stanley have lowered price targets and maintain Equal Weight ratings. The consensus reflects cautious optimism, with concerns over supply chain issues and timing-related revenue constraints.

Wall Street analysts forecast NTNX stock price to rise
14 Analyst Rating
Wall Street analysts forecast NTNX stock price to rise
12 Buy
2 Hold
0 Sell
Strong Buy
Current: 38.630
sliders
Low
53
Averages
70.42
High
90
Current: 38.630
sliders
Low
53
Averages
70.42
High
90
Piper Sandler
James Fish
Overweight
to
Overweight
downgrade
$72 -> $63
AI Analysis
2026-02-26
Reason
Piper Sandler
James Fish
Price Target
$72 -> $63
AI Analysis
2026-02-26
downgrade
Overweight
to
Overweight
Reason
Piper Sandler analyst James Fish lowered the firm's price target on Nutanix (NTNX) to $63 from $72 and keeps an Overweight rating on the shares. With a 2% beat and only $20M FY26 top-line guide cut, shares are pointed 15% higher as fears of a larger cut were overblown, the firm says. While a cut is never something Piper likes to see, and caused by macro-factors and not execution, the firm is encouraged by the highest net-new customer additions in 8 years, TCV bookings growing mid-teens and outpacing revenue growth this year, contribution from OEM partners, and the new AMD (AMD) partnership.
Barclays
Tim Long
Equal Weight
downgrade
$53 -> $47
2026-02-26
Reason
Barclays
Tim Long
Price Target
$53 -> $47
2026-02-26
downgrade
Equal Weight
Reason
Barclays analyst Tim Long lowered the firm's price target on Nutanix to $47 from $53 and keeps an Equal Weight rating on the shares. The company reported a good quarter but issued another fiscal year sales guidance cut, the analyst tells investors in a research note. The firm says timing issues are affecting revenue recognition for the year.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for NTNX
Unlock Now

People Also Watch